(12) A main process started by GHS-R1a involves an enzyme called phospholipase C (PLC)
Patients who experience side effects, plateaus, or inadequate response on one medication can switch to another
In the event of a national shortage in which Mounjaro is commercially unavailable according to the FDA, your physician may recommend compounded tirzepatide (the active ingredient in Mounjaro ) as an alternative treatment option.* *Mounjaro is not a weight loss drug
These products are not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, weight-loss use, medical use, supplement use, wellness use or any form of personal use
Notably, these medications are not recommended for patients with severe gastroparesis or other significant gastrointestinal disorders, as stated in their FDA labeling
Neither platform guarantees advanced metabolic assessment or genetic risk evaluation